Experimental Infant Formula
OtherInfant formula to be fed ad libitum
Other names: EleCare
NCT Number: NCT01812629
The study objective is to assess the growth, tolerance and efficacy of a complete amino acid-based medical food in children with chronic diarrhea.
Looking for future studies?
Notify MeUp to 9 month
All sexes
Interventional
Not applicable
Children's National Medical Center, Washington D.C., District of Columbia, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Infant formula to be fed ad libitum
Other names: EleCare
Time frame: Study Day (SD)1-84
Outcome dependent on individual subject assessment and may include decreased stool number, decreased vomiting, decreased gas, weight gain, increased caloric intake, increased protein intake, increased serum albumin concentration, increased hemoglobin concentration, better acceptance of supplemental formula.
Time frame: Study day (SD) 2-4, 5-7, 25-27 and 81-83
Parent completed record of infant dietary intake.
Time frame: Study Day (SD) 2-4, 5-7, 25-27, 81-83
Parent reported record of incidence of regurgitation.
Time frame: Study Day (SD) 2-4, 5-7, 25-27 and 81-83
Parent completed diary of stool consistency, frequency/volume.
Time frame: Study Day (SD) 1 and 84
Hemoglobin, hematocrit, serum albumin, total protein, urea nitrogen, alkaline phosphatase
Time frame: Study Day (SD) 1, 28 and 84
Weight and length
Abbott Nutrition
Industry
Clinical Management of Children With Chronic Diarrhea
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01820494
Growth and Tolerance Infant Study
Baltimore, Maryland, United States
View Trial Details